These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 24714748)
1. Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells. Boudreau HE; Casterline BW; Burke DJ; Leto TL Br J Cancer; 2014 May; 110(10):2569-82. PubMed ID: 24714748 [TBL] [Abstract][Full Text] [Related]
2. Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to-mesenchymal transition and migration of breast epithelial cells. Boudreau HE; Casterline BW; Rada B; Korzeniowska A; Leto TL Free Radic Biol Med; 2012 Oct; 53(7):1489-99. PubMed ID: 22728268 [TBL] [Abstract][Full Text] [Related]
3. Mutant p53 and NOX4 are modulators of a CCL5-driven pro-migratory secretome. Boudreau HE; Korzeniowska A; Leto TL Free Radic Biol Med; 2023 Apr; 199():17-25. PubMed ID: 36804453 [TBL] [Abstract][Full Text] [Related]
4. TGF-β promote epithelial-mesenchymal transition via NF-κB/NOX4/ROS signal pathway in lung cancer cells. Ma M; Shi F; Zhai R; Wang H; Li K; Xu C; Yao W; Zhou F Mol Biol Rep; 2021 Mar; 48(3):2365-2375. PubMed ID: 33792826 [TBL] [Abstract][Full Text] [Related]
5. Histone modifications affect differential regulation of TGFβ- induced NADPH oxidase 4 (NOX4) by wild-type and mutant p53. Boudreau HE; Ma WF; Korzeniowska A; Park JJ; Bhagwat MA; Leto TL Oncotarget; 2017 Jul; 8(27):44379-44397. PubMed ID: 28574838 [TBL] [Abstract][Full Text] [Related]
7. Nox4-derived ROS signaling contributes to TGF-β-induced epithelial-mesenchymal transition in pancreatic cancer cells. Hiraga R; Kato M; Miyagawa S; Kamata T Anticancer Res; 2013 Oct; 33(10):4431-8. PubMed ID: 24123012 [TBL] [Abstract][Full Text] [Related]
8. Nox4 Plays a Role in TGF-β-Dependent Lens Epithelial to Mesenchymal Transition. Das SJ; Lovicu FJ; Collinson EJ Invest Ophthalmol Vis Sci; 2016 Jul; 57(8):3665-73. PubMed ID: 27403995 [TBL] [Abstract][Full Text] [Related]
9. TGF-β1-induced cell migration in pancreatic carcinoma cells is RAC1 and NOX4-dependent and requires RAC1 and NOX4-dependent activation of p38 MAPK. Witte D; Bartscht T; Kaufmann R; Pries R; Settmacher U; Lehnert H; Ungefroren H Oncol Rep; 2017 Dec; 38(6):3693-3701. PubMed ID: 29039574 [TBL] [Abstract][Full Text] [Related]
10. Immune Cell Induced Migration of Osteoprogenitor Cells Is Mediated by TGF-β Dependent Upregulation of NOX4 and Activation of Focal Adhesion Kinase. Ehnert S; Linnemann C; Aspera-Werz RH; Bykova D; Biermann S; Fecht L; De Zwart PM; Nussler AK; Stuby F Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065198 [TBL] [Abstract][Full Text] [Related]
12. A mitochondrial ROS pathway controls matrix metalloproteinase 9 levels and invasive properties in RAS-activated cancer cells. Mori K; Uchida T; Yoshie T; Mizote Y; Ishikawa F; Katsuyama M; Shibanuma M FEBS J; 2019 Feb; 286(3):459-478. PubMed ID: 30281903 [TBL] [Abstract][Full Text] [Related]
13. Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene. Lam S; Wiercinska E; Teunisse AF; Lodder K; ten Dijke P; Jochemsen AG Breast Cancer Res Treat; 2014 Nov; 148(1):7-18. PubMed ID: 25257729 [TBL] [Abstract][Full Text] [Related]
14. NRF2 level is negatively correlated with TGF-β1-induced lung cancer motility and migration via NOX4-ROS signaling. Ryu D; Lee JH; Kwak MK Arch Pharm Res; 2020 Dec; 43(12):1297-1310. PubMed ID: 33242180 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis. Wendt MK; Schiemann WP Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433 [TBL] [Abstract][Full Text] [Related]
16. NADPH oxidase 4 is an oncoprotein localized to mitochondria. Graham KA; Kulawiec M; Owens KM; Li X; Desouki MM; Chandra D; Singh KK Cancer Biol Ther; 2010 Aug; 10(3):223-31. PubMed ID: 20523116 [TBL] [Abstract][Full Text] [Related]
17. SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling. Lv X; Yu H; Zhang Q; Huang Q; Hong X; Yu T; Lan H; Mei C; Zhang W; Luo H; Pang P; Shan H J Cell Mol Med; 2020 Sep; 24(18):10714-10729. PubMed ID: 32746503 [TBL] [Abstract][Full Text] [Related]